GLS and colorectal carcinoma: After knocking-down PKM2/GLS1 expression, reduced IC50 was observed in both THC8307 and THC8307/Oxa cell lines, suggesting that PKM2/GLS1 downregulation could enhance the sensitivity for oxaliplatin and/or reverse drug-resistance in CRC cell lines.